VQ-SAP X is a premium triterpenoid saponin fraction derived from the strictly selected inner bark of the Soapbark tree (Quillaja saponaria Molina). Developed using proprietary chromatographic separation technology, it is engineered to isolate highly active synergistic bioactive fractions that support strong immune stimulation while reducing reactogenicity. This advanced vaccine adjuvant is designed for use in recombinant protein vaccines, subunit vaccines, and mRNA vaccine formulations, where consistent immunogenic performance and improved tolerability are critical. Its refined composition makes it especially valuable for premium veterinary vaccine development, where adjuvant quality directly impacts efficacy, safety, and formulation stability. VQ-SAP X is positioned for manufacturers and formulators seeking a high-performance saponin-based adjuvant for next-generation vaccine applications.
Key Features
| Features | Description |
|---|---|
| Product Type | Premium triterpenoid saponin fraction |
| Botanical Source | Strictly selected inner bark of Soapbark tree (Quillaja saponaria Molina) |
| Processing Technology | Proprietary chromatographic separation technology |
| Immune Performance | Designed to maximize immune response and immunogenicity |
| Reduced Reactogenicity | Engineered to significantly reduce side effects |
| Target Applications | Recombinant protein, subunit, and mRNA vaccines |
| Industry Focus | Highly recommended for premium veterinary vaccine formulations |
| Attributes | Description |
|---|---|
| Product Name | VQ-SAP X |
| Brand/Store Name | Swasti Exports |
| MOQ | 1 |
| Product Form | Saponin fraction |
| Source Material | Inner bark of Quillaja saponaria Molina |
| Extraction Method | Proprietary chromatographic separation |
| Application | Vaccine adjuvant |
| Compatibility | Recombinant protein, subunit, and mRNA vaccines |
| Primary Use Case | Premium veterinary vaccine formulations |
| Performance Focus | High immunogenicity with reduced reactogenicity |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
VQ-SAP X is refined using proprietary chromatographic separation technology to isolate synergistic bioactive fractions, which is intended to improve immunogenic response while reducing reactogenicity compared with less purified saponin materials.
It is designed for recombinant protein vaccines, subunit vaccines, and mRNA vaccine formulations, where a strong adjuvant effect and controlled side-effect profile are important.
The product is derived from strictly selected inner bark of Quillaja saponaria Molina, which supports consistent raw material selection and is important for producing a premium, reproducible saponin fraction.
Yes. The product description highlights it as highly recommended for premium veterinary vaccine formulations, making it especially relevant for animal health vaccine development.
It is engineered to maximize immune response and immunogenicity while significantly reducing reactogenicity, helping formulators balance potency with tolerability.
Inclusive of all taxes
You Save: 0
Vadodara , India
Manufacturer, Trader, Exporter, Importer
GST- 24AIXPB0733C1ZO
Trust Mark
